Press Releases

Active Biotech's rights issue substantially oversubscribed
June 15, 2009 08:30 (CEST)
Active Biotech Presents Data regarding the 57-57 SLE Project at EULAR
June 11, 2009 08:30 (CEST)
Active Biotech Completes Patient Enrollment to TASQ Clinical Phase II study
June 8, 2009 08:30 (CEST)
Active Biotech Completes Patient Enrollment to ANYARA Phase III Clinical Trial
June 1, 2009 08:30 (CEST)
Announcement of prospectus regarding rights issue in Active Biotech AB (publ)
May 18, 2009 08:30 (CEST)
Annual General Meeting of Active Biotech AB
May 8, 2009 08:30 (CEST)
NEW DATA ILLUSTRATE NOVEL MECHANISM OF ACTION OF LAQUINIMOD, AN ORAL COMPOUND FOR THE TREATMENT OF MULTIPLE SCLEROSIS
April 28, 2009 15:00 (CEST)
Active Biotech presents S100A9 as a target for quinoline compounds
April 28, 2009 08:30 (CEST)
Active Biotech AB Interim report January-March 2009
April 23, 2009 08:30 (CEST)
Annual Report 2008 Active Biotech AB (publ)
April 6, 2009 08:32 (CEST)